Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

9 Meters Biopharma Inc (NMTR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2017	12-2016	12-2015	12-2014	12-2006
Cash Flows From Operating Activities
Net Income	-11,606	-6,213	-8,741	-11,057	N/A
Depreciation Amortization	45	1,837	993	1,147	N/A
Accounts receivable	N/A	-365	2,746	-3,100	N/A
Accounts payable and accrued liabilities	747	-753	-677	2,809	N/A
Other Working Capital	49	-3,647	4,941	-748	N/A
Other Operating Activity	5,669	714	-992	3,497	0
Operating Cash Flow	$-5,097	$-8,427	$-1,730	$-7,452	$N/A

Cash Flows From Investing Activities
PPE Investments	-39	N/A	N/A	N/A	N/A
Investing Cash Flow	$-39	$N/A	$N/A	$N/A	$N/A

Cash Flows From Financing Activities
Change In Short Term Borrowing	5,130	641	7,002	15,059	N/A
Debt Issued	N/A	406	4,600	3,466	N/A
Debt Repayment	N/A	-462	N/A	N/A	N/A
Common Stock Issued	N/A	8,824	2,969	N/A	N/A
Other Financing Activity	0	352	-12,819	-10,977	0
Financing Cash Flow	$5,130	$9,761	$1,752	$7,548	$N/A

Beginning Cash Position	361	119	97	1	N/A
End Cash Position	356	1,453	119	97	N/A
Net Cash Flow	$-5	$1,334	$22	$96	$N/A

Free Cash Flow
Operating Cash Flow	-5,097	-8,427	-1,730	-7,452	N/A
Capital Expenditure	-39	N/A	N/A	N/A	N/A
Free Cash Flow	-5,135	-8,427	-1,730	-7,452	0